AAPG: Ascentage Pharma Corp Cash Calculated per Single Share

Corporate emblem and logo of ascentage.com (AAPG)

Ascentage Pharma Group is overcoming a liquidity deficit by attracting investment, as confirmed by the cash per share analysis. The strategy is based on developing unique cancer drugs for the US and Chinese markets. The critical need for therapy, which remains independent of economic cycles, guarantees business resilience. The current level of the indicator is 3.00, capturing the company's financial trajectory.

Ascentage Pharma (AAPG): Cash per Share from 01/25/2025 to 11/20/2026

Analytical breakdowns for Ascentage Pharma (AAPG)

- current price and projected stock value:
- cash position and cash flow details:
Comprehensive company analysis:Ascentage (AAPG)
Original product of ascentage.com

Developing unique apoptosis protein inhibitors requires colossal R&D investments to capture the targeted therapy market. This metric is calculated by dividing the total volume of liquid assets by the number of shares outstanding, reflecting the internal reserve of Ascentage Pharma Group (AAPG) for financing clinical trials, which allows for an assessment of the issuer's financial stability through the annual dynamics of cash per share.

Key competitors

Cash Funds per Single Share ONC (BeiGene Corp)|Cash per Single Share HALO (Halozyme Therapeutics, Inc.)|Cash per Share Revolution Medicines, Inc. (RVMD)|Cash Funds per Share CG Oncology Therapeutics CGON|Amount of Cash per Share URGN|BCAX: Cash per Single Share|PSNL: Cash Funds per Share|Erasca (ERAS) - Cash Funds per Share|DCTH - Cash Funds Calculated per Share|YMAB (Y-mAbs Corp) - Cash per Share|Cash per Single Share Aura Biosciences (AURA)|Cash Funds per Share Candel Therapeutics Inc. (CADL)|Cash per Single Share Accuray, Inc. ARAY|Cash Funds per Share sellaslifesciences.com SLS|Amount of Cash per Share ACTU|CTOR - Cash Funds per Share|Cash Funds Calculated per Share tuhurabio.com HURA|Protara Therapeutics, Inc. (TARA) - Cash Funds per Share|FATE: Cash Calculated per Single Share|WHWK (Aadi Bioscience, Inc.) - Cash per Share|TCRX (TScan Therapeutics) - Cash Calculated per Single Share|Cash Funds per Share Champions Oncology (CSBR)|Cash Funds Calculated per Share XBiotech USA|Cash Funds per Share CEL-SCI CVM|OS Therapies, Inc. (OSTX) - Cash on Hand per Share|RADX - Cash Funds per Share|ARTV - Cash per Share|Adlai Nortye Ltd (ANL) - Cash Funds per Share|Veru Pharma - Amount of Cash per Share|Cash Funds per Share Tempest Therapeutics Corp|Cash Funds per Single Share XLO (Xilio Therapeutics, Inc.)|Cash per Share RENB|MURA (Mural Oncology) - Amount of Cash per Share|Cash per Share KAPA (Kairos Pharma Ltd)|OKUR: Cash Funds per Single Share|GDTC: Cash per Single Share|CRIS - Cash per Share|APLM: Cash per Share|Cash on Hand per Share tharimmune.com (THAR)|ADVB (Advanced Biomed Corp) - Cash per Share|Cash per Share Genprex Inc.|Cash per Share CLDI|Cash per Single Share Sunshine Biopharma, Inc. SBFM|Cash per Share XBIO (Xenetic Biosciences)|Amount of Cash per Share SLRX|PPBT - Cash Funds per Share|AONC (aoncology.com) - Cash Funds per Single Share|BGNE: Cash per Share|Checkpoint Therapeutics Inc (CKPT) - Cash per Share|ELEV (Elevation Oncology Inc.) - Cash per Share|icadmed.com (ICAD) - Cash Funds Calculated per Share|Cash per Share IKNA|NTBL (Notable Labs) - Amount of Cash per Share|Cash per Share VIRX (Viracta Therapeutics)|Cash Funds Calculated per Share MorphoSys AG (MOR)|NAYA Biosciences Corp - Cash per Share|Cash on Hand per Share ascentage.com